The potential prognostic, predictive, and therapeutic values of DNA methylation in cancer. Commentary re: J. Kwong et al., Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma. Clin. Cancer Res., 8: 131-137, 2002, and H-Z. Zou et al., Detection of aberrant p16 methylation in the serum of colorectal cancer patients. Clin. Cancer Res., 8: 188-191, 2002

Clin Cancer Res. 2002 Jan;8(1):17-21.
No abstract available

Publication types

  • Comment
  • Editorial
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Chromosome Aberrations
  • Cyclin-Dependent Kinase Inhibitor p16 / genetics
  • DNA Methylation*
  • DNA, Neoplasm / blood
  • DNA, Neoplasm / genetics*
  • Gene Expression
  • Gene Silencing
  • Humans
  • Microsatellite Repeats
  • Mutation
  • Neoplasms / diagnosis
  • Neoplasms / genetics*
  • Neoplasms / mortality
  • Predictive Value of Tests
  • Prognosis
  • Promoter Regions, Genetic
  • Survival Rate

Substances

  • Cyclin-Dependent Kinase Inhibitor p16
  • DNA, Neoplasm